Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
Attention deficit hyperactivity disorder (ADHD) affects 5-6% of school aged children worldwide. Pharmacological therapy is considered the first-line treatment and methylphenidate (MPH) is considered the first-choice medication. There are two formulations: immediate release (IR) MPH and long-acting (...
Saved in:
Main Authors: | Alfredo Durand-Rivera, Efren Alatorre-Miguel, Elizabeth Zambrano-Sánchez, Celia Reyes-Legorreta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2015/207801 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Recurrent Pancreatitis in a Child with ADHD after Starting Treatment with Methylphenidate (Ritalin)
by: Suheil Artul, et al.
Published: (2014-01-01) -
Actigraphic Recording of Manic Symptoms Induced by Methylphenidate
by: Tuuli Lahti, et al.
Published: (2009-01-01) -
Altered Functional Connectivity in Children with ADHD Revealed by Scalp EEG: An ERP Study
by: Chunli Chen, et al.
Published: (2021-01-01) -
General practice database on mortality in adults on methylphenidate: cohort study
by: Bruno Stricker, et al.
Published: (2022-08-01) -
Methylphenidate in COVID-19 Related Brain Fog: A Case Series
by: Debanjan Bhattacharjee, et al.
Published: (2025-01-01)